Cervical Dysplasia and Human Papillomavirus Infection in Rheumatoid Arthritis.

类风湿关节炎中的宫颈发育不良和人乳头瘤病毒感染。

基本信息

  • 批准号:
    8701235
  • 负责人:
  • 金额:
    $ 13.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-01 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): I am a Rheumatologist and Postdoctoral Fellow in the Division of Pharmacoepidemiology and Pharmacoeconomics and the Division of Rheumatology, Immunology and Allergy at Brigham and Women's Hospital (BWH), undertaking a training in Pharmacoepidemiology in the rheumatic diseases under the guidance of Drs. Daniel H. Solomon and Sebastian Schneeweiss. My long term goal is to establish a career as an independent pharmacoepidemiology researcher with expertise in the safety of drugs used in the rheumatic diseases. Previous studies have suggested that women with immunocompromised conditions including systemic lupus erythematosus, systemic sclerosis and ulcerative colitis are at a greater risk for cervical dysplasia and human papillomavirus (HPV) infection than are women in the general population. However, scant data exist regarding the risk of cervical dysplasia and HPV infection in rheumatoid arthritis (RA). I propose to use several integrative approaches to evaluate the risk of cervical dysplasia, cervical cancer and HPV infection in patients with RA, to relate the risks of these outcomes to different types of immunosuppressive therapy (i.e., traditional disease-modifying anti-rheumatic drugs versus biologic therapy) as well as demographic and other clinical factors and to examine adherence to current cervical cancer screening guidelines in patients with RA. I will be using different data sources including electronic medical records, large administrative databases, patient survey, as well as patient registries. With the advent of the cervical cancer vaccine, identification of women at high risk carries great
描述(由申请人提供):我是美国布莱根妇女医院(BWH)药物流行病学与药物经济学学部和风湿病、免疫与过敏学部的风湿病学家和博士后,在布里格姆妇女医院(BWH)风湿病、免疫与过敏学博士的指导下进行风湿病药物流行病学培训。Daniel H. Solomon和Sebastian Schneeweiss。我的长期目标是成为一名独立的药物流行病学研究人员,在风湿性疾病中使用的药物安全性方面具有专业知识。先前的研究表明,与普通人群相比,患有系统性红斑狼疮、系统性硬化症和溃疡性结肠炎等免疫功能低下疾病的女性患宫颈发育不良和人乳头瘤病毒(HPV)感染的风险更大。然而,关于类风湿性关节炎(RA)中宫颈发育不良和HPV感染的风险的数据很少。我建议使用几种综合方法来评估RA患者宫颈发育不良、宫颈癌和HPV感染的风险,将这些结果的风险与不同类型的免疫抑制治疗(即传统的改善疾病的抗风湿药物与生物治疗)以及人口统计学和其他临床因素联系起来,并检查RA患者对当前宫颈癌筛查指南的依从性。我将使用不同的数据源,包括电子病历、大型管理数据库、患者调查以及患者登记。随着宫颈癌疫苗的问世,对高危妇女的识别意义重大

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Patients' perception about risks and benefits of antithrombotic treatment for the prevention of venous thromboembolism (VTE) after orthopedic surgery: a qualitative study.
  • DOI:
    10.1186/s12891-015-0777-x
  • 发表时间:
    2015-10-26
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Najafzadeh M;Kim SC;Patterson C;Schneeweiss S;Katz JN;Brick GW;Ready JE;Polinski JM;Patorno E
  • 通讯作者:
    Patorno E
Patterns of bisphosphonates utilization in patients under age 45 in a large cohort of commercial insurance beneficiaries in the United States.
美国一大群商业保险受益人中 45 岁以下患者的双磷酸盐使用模式。
  • DOI:
    10.1371/journal.pone.0115091
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Xie,Jing;Tong,Angela;Kim,SeoyoungC
  • 通讯作者:
    Kim,SeoyoungC
Human papillomavirus vaccine uptake among individuals with systemic inflammatory diseases.
  • DOI:
    10.1371/journal.pone.0117620
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Feldman CH;Hiraki LT;Lii H;Seeger JD;Kim SC
  • 通讯作者:
    Kim SC
Gout: a review of nonmodifiable and modifiable risk factors.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Seoyoung Catherine Kim其他文献

Seoyoung Catherine Kim的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Seoyoung Catherine Kim', 18)}}的其他基金

Mentoring Patient-Oriented Pharmacoepidemiologic Research in Rheumatic Diseases
指导以患者为导向的风湿性疾病药物流行病学研究
  • 批准号:
    10187754
  • 财政年份:
    2021
  • 资助金额:
    $ 13.57万
  • 项目类别:
Mentoring Patient-Oriented Pharmacoepidemiologic Research in Rheumatic Diseases
指导以患者为导向的风湿性疾病药物流行病学研究
  • 批准号:
    10380014
  • 财政年份:
    2021
  • 资助金额:
    $ 13.57万
  • 项目类别:
Comparative Effectiveness of Treat-To-Target Approach versus Routine Care in Management of Gout
痛风治疗中目标治疗方法与常规护理的效果比较
  • 批准号:
    9975704
  • 财政年份:
    2019
  • 资助金额:
    $ 13.57万
  • 项目类别:
Comparative Effectiveness of Treat-To-Target Approach versus Routine Care in Management of Gout
痛风治疗中目标治疗方法与常规护理的效果比较
  • 批准号:
    10176417
  • 财政年份:
    2019
  • 资助金额:
    $ 13.57万
  • 项目类别:
Use and safety of opioids in patients undergoing total joint replacement
阿片类药物在全关节置换术患者中的使用和安全性
  • 批准号:
    9761438
  • 财政年份:
    2016
  • 资助金额:
    $ 13.57万
  • 项目类别:
Use and safety of opioids in patients undergoing total joint replacement
阿片类药物在全关节置换术患者中的使用和安全性
  • 批准号:
    9355032
  • 财政年份:
    2016
  • 资助金额:
    $ 13.57万
  • 项目类别:
Xanthine oxidase inhibitors and risks of myocardial infarction and diabetes
黄嘌呤氧化酶抑制剂与心肌梗塞和糖尿病的风险
  • 批准号:
    9018734
  • 财政年份:
    2016
  • 资助金额:
    $ 13.57万
  • 项目类别:
Xanthine oxidase inhibitors and risks of myocardial infarction and diabetes
黄嘌呤氧化酶抑制剂与心肌梗塞和糖尿病的风险
  • 批准号:
    9230337
  • 财政年份:
    2016
  • 资助金额:
    $ 13.57万
  • 项目类别:
Cervical Dysplasia and Human Papillomavirus Infection in Rheumatoid Arthritis.
类风湿关节炎中的宫颈发育不良和人乳头瘤病毒感染。
  • 批准号:
    8307483
  • 财政年份:
    2010
  • 资助金额:
    $ 13.57万
  • 项目类别:
Cervical Dysplasia and Human Papillomavirus Infection in Rheumatoid Arthritis.
类风湿关节炎中的宫颈发育不良和人乳头瘤病毒感染。
  • 批准号:
    8116599
  • 财政年份:
    2010
  • 资助金额:
    $ 13.57万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 13.57万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 13.57万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 13.57万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 13.57万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 13.57万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 13.57万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 13.57万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 13.57万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 13.57万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 13.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了